Perlecan Domain V Is Neuroprotective and Affords Functional Improvement in a Photothrombotic Stroke Model in Young and Aged Mice

Translational Stroke Research

Volumn 4, Issue 5, 2013, Pages 515-523

  Bix, Gregory J ^a   Gowing, Emma K ^b   Clarkson, Andrew N ^b  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Behavioral recovery; Cerebral infarct; Extracellular matrix

Indexed keywords

GLIAL FIBRILLARY ACIDIC PROTEIN; NEUROPROTECTIVE AGENT; PERLECAN DOMAIN V; PHOSPHATE BUFFERED SALINE; UNCLASSIFIED DRUG;

AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN INFARCTION; BRAIN INFARCTION SIZE; CONTROLLED STUDY; FUNCTIONAL ASSESSMENT; MALE; MOTOR CORTEX; MOUSE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TASK PERFORMANCE; WALKING;

AGE FACTORS; ANIMALS; BENZOFURANS; DISEASE MODELS, ANIMAL; HEPARAN SULFATE PROTEOGLYCANS; MICE; NEUROPROTECTIVE AGENTS; QUINOLINES; STROKE; TREATMENT OUTCOME;

EID: 84884901075     PISSN: 18684483     EISSN: 1868601X     Source Type: Journal    
DOI: 10.1007/s12975-013-0266-1     Document Type: Article

References (32)

1. Al-Ahmad AJ, Lee B, Saini M, Bix GJ. Perlecan domain V modulates astrogliosis in vitro and after focal cerebral ischemia through multiple receptors and increased nerve growth factor release. Glia. 2011;59: 1822-40.
2. Baskin YK, Dietrich WD, Green EJ. Two effective behavioral tasks for evaluating sensorimotor dysfunction following traumatic brain injury in mice. J Neurosci Methods. 2003;129: 87-93.
3. Bix G, Castello R, Burrows M, Zoeller JJ, Weech M, Iozzo RA, et al. Endorepellin in vivo: targeting the tumor vasculature and retarding cancer growth and metabolism. J Natl Cancer Inst. 2006;98: 1634-46.
4. Bix G, Fu J, Gonzalez EM, Macro L, Barker A, Campbell S, et al. Endorepellin causes endothelial cell disassembly of actin cytoskeleton and focal adhesions through alpha2beta1 integrin. J Cell Biol. 2004;166: 97-109.
5. Boroujerdi A, Welser-Alves JV, Tigges U, Milner R. Chronic cerebral hypoxia promotes arteriogenic remodeling events that can be identified by reduced endoglin (CD105) expression and a switch in beta1 integrins. J Cereb Blood Flow Metab. 2012;32: 1820-30.
6. Braun JS, Jander S, Schroeter M, Witte OW, Stoll G. Spatiotemporal relationship of apoptotic cell death to lymphomonocytic infiltration in photochemically induced focal ischemia of the rat cerebral cortex. Acta Neuropathol. 1996;92: 255-63.
7. Brott T, Marler JR, Olinger CP, Adams Jr HP, Tomsick T, Barsan WG, et al. Measurements of acute cerebral infarction: lesion size by computed tomography. Stroke. 1989;20: 871-5.
8. Carmichael ST. Plasticity of cortical projections after stroke. Neuroscientist. 2003;9: 64-75.
9. Carmichael ST. Rodent models of focal stroke: size, mechanism, and purpose. NeuroRx. 2005;2: 396-409.
10. Chen F, Suzuki Y, Nagai N, Jin L, Yu J, Wang H, et al. Rodent stroke induced by photochemical occlusion of proximal middle cerebral artery: evolution monitored with MR imaging and histopathology. Eur J Radiol. 2007;63: 68-75.
11. Clarke DN, Al Ahmad A, Lee B, Parham C, Auckland L, Fertala A, et al. Perlecan domain V induces VEGf secretion in brain endothelial cells through integrin alpha5beta1 and ERK-dependent signaling pathways. PLoS One. 2012;7: e45257.
12. Clarkson AN, Huang BS, Macisaac SE, Mody I, Carmichael ST. Reducing excessive GABA-mediated tonic inhibition promotes functional recovery after stroke. Nature. 2010;468: 305-9.
13. Clarkson AN, Lopez-Valdes HE, Overman JJ, Charles AC, Brennan KC, Thomas Carmichael S. Multimodal examination of structural and functional remapping in the mouse photothrombotic stroke model. J Cereb Blood Flow Metab. 2013;33: 716-23.
14. Clarkson AN, Overman JJ, Zhong S, Mueller R, Lynch G, Carmichael ST. AMPA receptor-induced local brain-derived neurotrophic factor signaling mediates motor recovery after stroke. J Neurosci. 2011;31: 3766-75.
15. Dinapoli VA, Huber JD, Houser K, Li X, Rosen CL. Early disruptions of the blood-brain barrier may contribute to exacerbated neuronal damage and prolonged functional recovery following stroke in aged rats. Neurobiol Aging. 2008;29: 753-64.
16. Dobkin BH. Training and exercise to drive poststroke recovery. Nat Clin Pract Neurol. 2008;4: 76-85.
17. Hansen TM, Moss AJ, Brindle NP. Vascular endothelial growth factor and angiopoietins in neurovascular regeneration and protection following stroke. Curr Neurovasc Res. 2008;5: 236-45.
18. Kelly-Hayes M, Beiser A, Kase CS, Scaramucci A, D'agostino RB, Wolf PA. The influence of gender and age on disability following ischemic stroke: the Framingham study. J Stroke Cerebrovasc Dis. 2003;12: 119-26.
19. Lee B, Clarke D, Al Ahmad A, Kahle M, Parham C, Auckland L, et al. Perlecan domain V is neuroprotective and proangiogenic following ischemic stroke in rodents. J Clin Invest. 2011;121: 3005-23.
20. Liu F, Yuan R, Benashski SE, Mccullough LD. Changes in experimental stroke outcome across the life span. J Cereb Blood Flow Metab. 2009;29: 792-802.
21. Lo EH. A new penumbra: transitioning from injury into repair after stroke. Nat Med. 2008;14: 497-500.
22. Lo EH, Dalkara T, Moskowitz MA. Mechanisms, challenges and opportunities in stroke. Nat Rev Neurosci. 2003;4: 399-415.
23. Milner R, Hung S, Wang X, Berg GI, Spatz M, Del Zoppo GJ. Responses of endothelial cell and astrocyte matrix-integrin receptors to ischemia mimic those observed in the neurovascular unit. Stroke. 2008;39: 191-7.
24. Ohab JJ, Fleming S, Blesch A, Carmichael ST. A neurovascular niche for neurogenesis after stroke. J Neurosci. 2006;26: 13007-16.
25. Popa-Wagner A, Buga AM, Kokaia Z. Perturbed cellular response to brain injury during aging. Ageing Res Rev. 2011;10: 71-9.
26. Rolls A, Shechter R, Schwartz M. The bright side of the glial scar in CNS repair. Nat Rev Neurosci. 2009;10: 235-41.
27. Saver JL, Albers GW, Dunn B, Johnston KC, Fisher M. Stroke Therapy Academic Industry Roundtable (STAIR) recommendations for extended window acute stroke therapy trials. Stroke. 2009;40: 2594-600.
28. Schallert T, Fleming SM, Leasure JL, Tillerson JL, Bland ST. CNS plasticity and assessment of forelimb sensorimotor outcome in unilateral rat models of stroke, cortical ablation, parkinsonism and spinal cord injury. Neuropharmacol. 2000;39: 777-87.
29. Sun Y, Jin K, Xie L, Childs J, Mao XO, Logvinova A, et al. VEGF-induced neuroprotection, neurogenesis, and angiogenesis after focal cerebral ischemia. J Clin Invest. 2003;111: 1843-51.
30. Truelsen T, Piechowski-Jozwiak B, Bonita R, Mathers C, Bogousslavsky J, Boysen G. Stroke incidence and prevalence in Europe: a review of available data. Eur J Neurol. 2006;13: 581-98.
31. Yao H, Yoshii N, Akira T, Nakahara T. Reperfusion-induced temporary appearance of therapeutic window in penumbra after 2 h of photothrombotic middle cerebral artery occlusion in rats. J Cereb Blood Flow Metab. 2009;29: 565-74.
32. Zhang ZG, Zhang L, Jiang Q, Zhang R, Davies K, Powers C, et al. VEGF enhances angiogenesis and promotes blood-brain barrier leakage in the ischemic brain. J Clin Invest. 2000;106: 829-38.